Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7725-7730

  Boehm, Nils ^a   Riechardt, Aline I ^a,b   Wiegand, Michaela ^a   Pfeiffer, Norbert ^a   Grus, Franz H ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CYSTATIN S; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCALIN 1; TEAR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; EYE PROTEIN; IL6 PROTEIN, HUMAN; TEAR PROTEINS;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRY EYE; EYE EXAMINATION; FEMALE; HUMAN; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SCHIRMER TEST; CHEMISTRY; CHILD; CLASSIFICATION; INFANT; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRY EYE SYNDROMES; EYE PROTEINS; FEMALE; HUMANS; INFANT; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; TEARS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84856367114     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7266     Document Type: Article

References (50)

1. Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol. 1995; 233:555-558.
2. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136: 318-326.
3. Moss SE, Klein R, Klein BE. Incidence of dry eye in an older population. Arch Ophthalmol. 2004;122:369-373.
4. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21:221-232.
5. Rivas L, Oroza MA, Perez-Esteban A, Murube-del-Castillo J. Morphological changes in ocular surface in dry eyes and other disorders by impression cytology. Graefes Arch Clin Exp Ophthalmol. 1992; 230:329-334.
6. Hikichi T, Yoshida A, Tsubota K. Lymphocytic infiltration of the conjunctiva and the salivary gland in Sjögren 's syndrome. Arch Ophthalmol. 1993;111:21-22.
7. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjögren 's and non-Sjögren 's patients with dry eye. Invest Ophthalmol Vis Sci. 2002;43:2609-2614.
8. Tsubota K, Fujihara T, Saito K, Takeuchi T. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica. 1999;213:16-19.
9. Graham RR, Ortmann W, Rodine P, et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet. 2007;15:823-830.
10. Grus FH, Dick B, Augustin AJ, Pfeiffer N. Analysis of the antibody repertoire in tears of dry eye patients. Ophthalmologica. 2001; 215:430-434.
11. Zhou L, Beuerman RW, Chan CM, et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res. 2009;8:4889-4905.
12. Glasgow BJ, Gasymov OK, Abduragimov AR, Engle JJ, Casey RC. Tear lipocalin captures exogenous lipid from abnormal corneal surfaces. Invest Ophthalmol Vis Sci. 2010;51:1981-1987.
13. Yusifov TN, Abduragimov AR, Narsinh K, Gasymov OK, Glasgow BJ. Tear lipocalin is the major endonuclease in tears. Mol Vis. 2008;14:180-188.
14. Saaren-Seppala H, Jauhiainen M, Tervo TM, et al. Interaction of purified tear lipocalin with lipid membranes. Invest Ophthalmol Vis Sci. 2005;46:3649-3656.
15. Barka T, Asbell PA, van der Noen H, Prasad A. Cystatins in human tear fluid. Curr Eye Res. 1991;10:25-34.
16. Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol. 2000;118: 1489-1496.
17. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease: CsA Phase 3 Study Group. Ophthalmology. 2000;107:631-639.
18. Hoh H, Schirra F, Kienecker C, Ruprecht KW. [Lid-parallel conjunctival folds are a sure diagnostic sign of dry eye.] Ophthalmologe. 1995;92:802-808.
19. Research in dry eye: report of the Research Subcommittee of the International Dry Eye Workshop. Ocul Surf. 2007;5:179-193.
20. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surf. 2007;5:75-92.
21. Grus FHA, Augustin J. Analysis of tear protein patterns by a neural network as a diagnostical tool for the detection of dry eyes. Electrophoresis. 1999;20:875-880.
22. Grus FHA, Augustin J. High performance liquid chromatography analysis of tear protein patterns in diabetic and non-diabetic dry eye patients. Eur J Ophthalmol. 2001;11:19-24.
23. Versura P, Nanni P, Bavelloni A, et al. Tear proteomics in evaporative dry eye disease. Eye. 2010;24:1396-1402.
24. Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997;74: 8-13.
25. Maissa C, Guillon M. Tear film dynamics and lipid layer characteristics-effect of age and gender. Cont Lens Anterior Eye. 2010; 33:176-182.
26. Tong L, Chaurasia SS, Mehta JS, Beuerman RW. Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore. Invest Ophthalmol Vis Sci. 2010;51: 3449-3454.
27. Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003;1:107-126.
28. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. BioTechniques. 2003;34:374-378.
29. Saeed AI, Bhagabati NK, Braisted JC, et al. TM4 microarray software suite. Methods Enzymol. 2006;411:134-193.
30. Grus FH, Podust VN, Bruns K, et al. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci. 2005;46:863-876.
31. Kramann C, Boehm N, Lorenz K, et al. Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch Clin Exp Ophthalmol. 2011;249:233-243.
32. Janciauskiene S, Zelvyte I, Jansson L, Stevens T. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro. Biochem Biophys Res Commun. 2004;315:288-296.
33. Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol. 1997;100: 817-824.
34. Barton K, Monroy DC, Nava A, Pflugfelder SC. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology. 1997;104:1868-1874.
35. Bernauer W, Wright P, Dart JK, Leonard JN, Lightman S. Cytokines in the conjunctiva of acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis. Graefes Arch Clin Exp Ophthalmol. 1993;231:563-570.
36. Narayanan S, Miller WL, McDermott AM. Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest Ophthalmol Vis Sci. 2006;47:2445-2450.
37. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19:201-211.
38. Massingale ML, Li X, Vallabhajosyula M, et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009; 28:1023-1027.
39. Li S, Sack R, Vijmasi T, et al. Antibody protein array analysis of the tear film cytokines. Optom Vis Sci. 2008;85:653-660.
40. Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea. 2007;26:431-437.
41. Lam H, Bleiden L, de Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147:198-205, e1.
42. Solomon A, Dursun D, Liu Z, et al. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
43. Dougherty JM, McCulley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:486-491.
44. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007; 148:32-46.
45. Zheng X, de Paiva CS, Li DQ, Farley WJ, Pflugfelder SC. Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Invest Ophthalmol Vis Sci. 2010;51:3083-3091.
46. De Paiva CS, Chotikavanich S, Pangelinan SB, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. 2009;2:243-253.
47. Albertsmeyer AC, Kakkassery V, Spurr-Michaud S, Beeks O, Gipson IK. Effect of proinflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp Eye Res. 2010;90:444-451.
48. Thathiah A, Brayman M, Dharmaraj N, et al. Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line. Endocrinology. 2004;145:4192-4203.
49. Paulsen F, Jager K, Worlitzsch D, et al. Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines. Ann Anat. 2008;190:59-70.
50. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22: 640-650.